Evidence map›Paper›PMID 34755130›Full record

Trial reportCell reports. Medicine2021

High-resolution epitope mapping by AllerScan reveals relationships between IgE and IgG repertoires during peanut oral immunotherapy.

Genghao Chen, Ellen L Shrock, Mamie Z Li, Jonathan M Spergel, Kari C Nadeau, Jacqueline A Pongracic, Dale T Umetsu, Rima Rachid, Andrew J MacGinnitie, Wanda Phipatanakul and 3 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Cell reports. Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Emerging Therapies for Anaphylaxis.Immunology and allergy clinics of North America · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Whence and wherefore IgE?Immunological reviews · 2024
    Review
  14. Neutralizing IgGThe Journal of allergy and clinical immunology · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Genghao ChenDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Ellen L ShrockDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Mamie Z LiDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Jonathan M SpergelDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kari C NadeauDepartment of Medicine, Sean N Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, CA, USA.
Jacqueline A PongracicDivision of Pediatric Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Dale T UmetsuDivision of Immunology, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
Rima RachidDivision of Immunology, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
Andrew J MacGinnitieDivision of Immunology, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
Wanda PhipatanakulDivision of Immunology, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
Lynda SchneiderDivision of Immunology, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
Hans C OettgenDivision of Immunology, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
Stephen J ElledgeDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Boston Children's Hospital · USBrigham and Women's Hospital · USAllergy, Asthma and Clinical Research Center · USChildren's Hospital of Philadelphia · USNorthwestern University · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
Treatment of Peanut Allergy with Intradermal Administration of ASP0892 (ARA-LAMP-vax): A Randomized, Double-Blind, Placebo-Controlled, Phase I/II StudyUM2AI130836 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KEET, CORINNE · 2017 to 2023
$62.1M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Controlling and preventing Asthma progression and Severity in Kids (CASK)U01AI126614 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI PHIPATANAKUL, WANDA · 2016 to 2023
$21.0M
Tracking allergen specific T cells in multi-food allergyU19AI104209 · NIAID · STANFORD UNIVERSITY · PI CHINTHRAJAH, R. SHARON · 2013 to 2025
$17.3M
Mast cell regulation of Th2 induction and tolerance breakdown in food allergyR01AI119918 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI OETTGEN, HANS C · 2015 to 2025
$5.6M
T Cell Reagent Research for Monitoring T Cell in Food AllergyU01AI140498 · NIAID · STANFORD UNIVERSITY · PI NADEAU, KARI C. · 2018 to 2022
$1.8M
Effects of IgE Blockade on T Cells in Food AllergyR01AI140134 · NIAID · STANFORD UNIVERSITY · PI NADEAU, KARI C. · 2018 to 2021
$1.6M
NCATS NIH HHS UL1 TR001102NCATS NIH HHS UL1 TR001422NIAID NIH HHS R01 AI119918NIAID NIH HHS R01 AI140134NIAID NIH HHS U01 AI126614NIAID NIH HHS U01 AI140498NIAID NIH HHS U19 AI104209NIAID NIH HHS UM2 AI130836
6 · The paper itself

Abstract

Peanut allergy can result in life-threatening reactions and is a major public health concern. Oral immunotherapy (OIT) induces desensitization to food allergens through administration of increasing amounts of allergen. To dissect peanut-specific immunoglobulin E (IgE) and IgG responses in subjects undergoing OIT, we have developed AllerScan, a method that leverages phage-display and next-generation sequencing to identify the epitope targets of peanut-specific antibodies. We observe a striking diversification and boosting of the peanut-specific IgG repertoire after OIT and a reduction in pre-existing IgE levels against individual epitopes. High-resolution epitope mapping reveals shared recognition of public epitopes in Ara h 1, 2, 3, and 7. In individual subjects, OIT-induced IgG specificities overlap extensively with IgE and exhibit strikingly similar antibody footprints, suggesting related clonal lineages or convergent evolution of peanut-specific IgE and IgG B cells. Individual differences in epitope recognition identified via AllerScan could inform safer and more effective personalized immunotherapy.

Indexed as

2S Albumins, PlantAntigens, PlantArachisB-LymphocytesCase-Control StudiesDesensitization, ImmunologicEpitope MappingEpitopesHigh-Throughput Nucleotide SequencingHigh-Throughput Screening AssaysHumansImmunoglobulin EImmunoglobulin GMembrane ProteinsOmalizumabPeanut Hypersensitivity2S Albumins, Plantallergen Ara h3Antigens, PlantAra h 1 protein, Arachis hypogaeaAra h 2 allergen, Arachis hypogaeaEpitopesImmunoglobulin EImmunoglobulin GMembrane ProteinsOmalizumabPeptide LibraryPlant ProteinsSeed Storage Proteinsallergen immunotherapyantibodyantibody repertoireepitope mappingfood allergyhigh-throughput sequencingIgEoral immunotherapypeanut allergyphage display

Identifiers

PMID34755130
PMCPMC8563412
OpenAlexW3207552006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.